Hyperamylasemia

1

Review clinical trials related to Hyperamylasemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety

Recent evidence suggests that postoperative hyperamylasemia (POH) is a predictor of morbidity after pancreatectomy. This is based on the assumption that pancreatitis after pancreatectomy (PPAP) is a major trigger for the development of complications and is indicated by hyperamylasemia. Standardized prospective analysis and correlation with other laboratory parameters, hasn't been performed to date. Therefore the overall study aims are: * To prospectively evaluate the incidence and assess the clinical value of biochemical changes for the postoperative course. * To confirm and improve the definition and classification of postpancreatectomy acute pancreatitis (PPAP) of the International Study Group of Pancreatic Surgery (ISGPS) and to provide knowledge for effective early management of complications.

Participants needed: 150
Trial details
Age: 18-85Biological sex: AllType: ObservationalSponsor: Technische Universität DresdenUpdated: Feb 3, 2026Locations: 1
Eligibility criteria

All patients undergoing pancreatic resection for malignant and benign disease wi... [+2]

Necrosectomy (endoscopic or open) for primary acute pancreatitis or within lapar... [+4]